Naomi Kawaguchi

622 total citations
28 papers, 477 citations indexed

About

Naomi Kawaguchi is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Naomi Kawaguchi has authored 28 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Hepatology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Naomi Kawaguchi's work include Liver Disease Diagnosis and Treatment (10 papers), Liver Diseases and Immunity (10 papers) and Hepatitis C virus research (4 papers). Naomi Kawaguchi is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Liver Diseases and Immunity (10 papers) and Hepatitis C virus research (4 papers). Naomi Kawaguchi collaborates with scholars based in Japan, Australia and United States. Naomi Kawaguchi's co-authors include Hiroshi Miyakawa, Hirotoshi Fujikawa, Masanao Matsushita, Kentaro Kikuchi, Atsushi Tanaka, Eric M. Gershwin, Makoto Kako, Carolyn L. Geczy, Kazuhiro Abe and Kenneth Hsu and has published in prestigious journals such as Hepatology, British Journal of Ophthalmology and Cytokine.

In The Last Decade

Naomi Kawaguchi

27 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naomi Kawaguchi Japan 12 297 271 97 77 63 28 477
Alessandro Pampana Italy 8 322 1.1× 260 1.0× 129 1.3× 32 0.4× 29 0.5× 17 520
Jorge Findor Argentina 12 410 1.4× 361 1.3× 119 1.2× 104 1.4× 32 0.5× 33 652
Yuko Arima Japan 12 175 0.6× 227 0.8× 22 0.2× 123 1.6× 44 0.7× 14 546
Barbara Guerrera Italy 12 557 1.9× 560 2.1× 117 1.2× 41 0.5× 69 1.1× 19 754
Tomoo Yamazaki Japan 16 406 1.4× 537 2.0× 23 0.2× 140 1.8× 173 2.7× 59 753
Mona Amin Egypt 9 94 0.3× 194 0.7× 38 0.4× 142 1.8× 38 0.6× 30 513
Benjamin Rivière France 9 119 0.4× 112 0.4× 38 0.4× 104 1.4× 51 0.8× 24 305
Montserrat Rivero Spain 13 394 1.3× 419 1.5× 29 0.3× 205 2.7× 52 0.8× 36 648
Ramazan Uçar Türkiye 10 70 0.2× 98 0.4× 22 0.2× 85 1.1× 48 0.8× 29 322
Laura Castelnovo Italy 9 68 0.2× 60 0.2× 58 0.6× 67 0.9× 36 0.6× 22 323

Countries citing papers authored by Naomi Kawaguchi

Since Specialization
Citations

This map shows the geographic impact of Naomi Kawaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Kawaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Kawaguchi more than expected).

Fields of papers citing papers by Naomi Kawaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Kawaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Kawaguchi. The network helps show where Naomi Kawaguchi may publish in the future.

Co-authorship network of co-authors of Naomi Kawaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Kawaguchi. A scholar is included among the top collaborators of Naomi Kawaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Kawaguchi. Naomi Kawaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiroshima, Yuka, Kenneth Hsu, Nicodemus Tedla, et al.. (2017). S100A8/A9 and S100A9 reduce acute lung injury. Immunology and Cell Biology. 95(5). 461–472. 45 indexed citations
2.
Kohashi, Keiichi, et al.. (2017). Effect of Smoking Status on Monocyte Tissue Factor Activity, Carotid Atherosclerosis and Long-Term Prognosis in Metabolic Syndrome. Circulation Journal. 82(5). 1418–1427. 11 indexed citations
3.
Wilkinson, Adam C., Naomi Kawaguchi, Carolyn L. Geczy, & Nick Di Girolamo. (2016). S100A8 and S100A9 proteins are expressed by human corneal stromal dendritic cells. British Journal of Ophthalmology. 100(9). 1304–1308. 7 indexed citations
5.
Fujii, Masanori, Hiroyuki Nakashima, Naomi Kawaguchi, et al.. (2013). Deficiency of n‐6 polyunsaturated fatty acids is mainly responsible for atopic dermatitis‐like pruritic skin inflammation in special diet‐fed hairless mice. Experimental Dermatology. 22(4). 272–277. 37 indexed citations
6.
Shibata, Minoru, Toshio Morizane, Naomi Kawaguchi, et al.. (2004). Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture. Journal of Gastroenterology. 39(3). 255–259. 37 indexed citations
7.
9.
Miyakawa, Hiroshi, Atsushi Tanaka, Kentaro Kikuchi, et al.. (2001). Detection of Antimitochondrial Autoantibodies in Immunofluorescent Ama–Negative Patients With Primary Biliary Cirrhosis Using Recombinant Autoantigens. Hepatology. 34(2). 243–248. 155 indexed citations
10.
Miyakawa, Hiroshi, Kentaro Kikuchi, Jong‐Hon Kang, et al.. (2001). High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis. Journal of Gastroenterology. 36(1). 33–38. 15 indexed citations
11.
Igarashi, Toshiko, et al.. (2001). Differences in Anti-LKM-1 Autoantibody Immunoreactivity to CYP2D6 Antigenic Sites Between Hepatitis C Virus-negative and -positive Patients. Journal of Autoimmunity. 17(3). 243–249. 17 indexed citations
12.
Miyakawa, Hiroshi, Kentaro Kikuchi, Hirotoshi Fujikawa, et al.. (2001). Immunoreactivity to Various Human Cytochrome P450 Proteins of Sera from Patients with Autoimmune Hepatitis, Chronic Hepatitis B, and Chronic Hepatitis C. Autoimmunity. 33(1). 23–32. 29 indexed citations
13.
Kawaguchi, Naomi, Yoshinori Kobayashi, Yasushi Miyauchi, et al.. (1999). Incidence and Clinical Significance of Junctional Rhythm Remaining After Termination of Radiofrequency Current Delivery in Patients With Atrioventricular Nodal Reentrant Tachycardia. Japanese Circulation Journal. 63(11). 865–872. 10 indexed citations
14.
Miyakawa, Hiroshi, Kazuhiro Abe, Kentaro Kikuchi, et al.. (1999). Detection of Anti-LKM-1(Anti-CYP2D6) by an: Enzyme-Linked Immunosorbent Assay in Adult Patients with Chronic Liver Diseases. Autoimmunity. 30(2). 107–114. 12 indexed citations
15.
Miyakawa, Hiroshi, et al.. (1998). A Case of acute hepatitis B transmitted from her husband with HBV carrier state after primary infection of HBV-genotype A.. Kanzo. 39(8). 533–538. 11 indexed citations
16.
Miyakawa, Hiroshi, Hiroshi Matsushima, Raleigh Hankins, et al.. (1998). Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients. Journal of Gastroenterology. 33(4). 529–535. 4 indexed citations
17.
Miyakawa, Hiroshi, Kazuhiro Abe, Naomi Kawaguchi, et al.. (1997). Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. Journal of Gastroenterology. 32(6). 769–776. 15 indexed citations
18.
Kobayashi, Yoshinori, Takeshi Ino, Yasushi Miyauchi, et al.. (1997). Curative percutaneous catheter ablation for various supraventricular and ventricular tachyarrhythmias. Results in 187 consecutive patients during the first five years.. Journal of Nippon Medical School. 64(6). 546–565. 1 indexed citations
19.
Endo, Takao, et al.. (1993). Dermatomyositis-polymyositis and malignancy. Is there a direct relation?. Journal of Nippon Medical School. 60(1). 50–53.
20.
Endo, Takao, et al.. (1993). Polymyositis-Dermatomyositis and Non-Hodgkin's Lymphoma.. Internal Medicine. 32(6). 487–489. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026